Antibiotic consumption and resistance selection Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue SUPPL. 2, 2002, Pages 27-37

  Baquero, Fernando ^a   Baquero Artigao, Gregorio ^b   Cantón, Rafael ^a   García Rey, César ^c  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Microbial Sciences Foundation   (Spain)

^c GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFUROXIME; CEPHALOSPORIN; ERYTHROMYCIN; MACROLIDE; NON PRESCRIPTION DRUG; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; COMMUNITY; CORRELATION ANALYSIS; CULTURAL FACTOR; DISEASE TRANSMISSION; DOSE TIME EFFECT RELATION; DRUG SELECTIVITY; DRUG USE; ECOLOGY; ERADICATION THERAPY; GEOGRAPHIC DISTRIBUTION; HEREDITY; HOST; HUMAN; INCIDENCE; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT ATTITUDE; PREVALENCE; PUBLIC HEALTH; REVIEW; SOCIOBIOLOGY; SOCIOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SYMPTOMATOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; PATIENT EDUCATION; SOCIOECONOMIC FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 12244275708     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf504     Document Type: Review

References (38)

1. Cars, O., Mölstad, S. & Melander, A. (2001). Variation in antibiotic use in the European Union. Lancet 357, 1851-3.
2. del Castillo, F., Baquero-Artigao, F. & García-Perea, A. (1998). Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatric Infectious Disease Journal 17, 94-7.
3. García-Rey, C., Aguilar, L., Baquero, F., Casal, J. & Dal-Ré, R. (2002). Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. Journal of Clinical Microbiology 40, 159-64.
4. Granizo, J. J., Aguilar, L., Casal, J., García-Rey, C., Dal-Ré, R. & Baquero, F. (2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997). Journal of Antimicrobial Chemotherapy 46, 767-73.
5. Felmingham, D. & Grüneberg, R. N. (2000). The Alexander Project 1996-1997: Latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 45, 191-203.
6. Baquero, F., Barrett, J. F., Courvalin, P., Morrisey, I., Piddock, L. & Novick, W. J. (1998). Epidemiology and mechanisms of resistance among respiratory tract pathogens. Clinical Microbiology and Infection 4, Suppl. 2, S19-26.
7. Pérez-Trallero, E., Fernández-Mazarrasa, C., García-Rey, C., Bouza, E., Aguilar, L., García-de-Lomas, J. et al. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrobial Agents and Chemotherapy 45, 3334-40.
8. Reig, M., Galán, J., Baquero, F. & Pérez-Díaz, J. C. (2001). Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes. Antimicrobial Agents and Chemotherapy 45, 630-2.
9. Austin, D. J., Kristinsson, K. G. & Anderson, R. M. (1999). The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences, USA 96, 1152-6.
10. Lipsitch, M. (2001). The rise and fall of antimicrobial resistance. Trends in Microbiology 9, 438-44.
11. López-Lozano, J. M., Monnet, D. L., Yague, A., Burgos, A., Gonzalo, N., Campillos, P. et al. (2000). Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. International Journal of Antimicrobial Agents 14, 21-31.
12. Ball, P., Baquero, F., Cars, O., File, T., Garau, J., Klugman, K. et al. (2002). Antibiotic therapy of community respiratory tract infections: strategies for optimizing outcomes and minimizing resistance emergence. Journal of Antimicrobial Chemotherapy 49, 31-40.
13. Cohen, R. & Varon, E. (2001). Flore rhinopharyngée: impact des traitements antibiotiques conventionnels. La Lettre de l'Infectiologue 16, 12-6.
14. Dagan, R., Klugman, K. P., Craig, W. A. & Baquero, F. (2001). Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. Journal of Antimicrobial Chemotherapy 47, 129-40.
15. Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroedan, F. et al. (1998). Low dosage and long treatment duration of β-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. Journal of the American Medical Association 279, 365-70.
16. Baquero, F., Negri, M. C., Morosini, M. I. & Blázquez, J. (1997). The antibiotic selective process: concentration-specific amplification of low-level resistant populations. Ciba Foundation Symposium 207, 93-111.
17. Schrag, S. J., Pena, C., Fernández, J., Sánchez, J., Gómez, V., Pérez, E. et al. (2001). Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage: a randomized trial. Journal of the American Medical Association 286, 49-56.
18. Kaye, C. M., Allen, A., Perry, S., McDonagh, M., Davy, M., Storm, K. et al. (2001). The clinical pharmacokinetics of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate. Clinical Therapeutics 23, 578-84.
19. Berry, V., Singley, C., Satterfield, J. & Woodnutt, G. (2001). Efficacy of a pharmacokinetically enhanced formulation of amoxicillin/clavulanate against experimental respiratory tract infection (RTI) in rats caused by Streptococcus pneumoniae (Sp.). In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract B-988, p. 53. American Society for Microbiology, Washington, DC, USA.
20. File, T., Jacobs, M., Poole, M., Richard, M. & Wynne, B. (2001). Clinical efficacy of pharmacokinetically enhanced amoxicillin/clavulanate (AMX/CA) vs. comparators against Streptococcus pneumoniae (Sp) in respiratory tract infections (RTIs). In Program and Abstracts of the Forty-first Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, 2001. Abstract L-866, p. 451. American Society for Microbiology, Washington, DC, USA.
21. Lipsitch, M. (2001). Measuring and interpreting associations between antibiotics and penicillin resistance in Streptococcus pneumoniae. Clinical Infectious Diseases 32, 1044-54.
22. Negri, M. C., Morosini, M. I., Loza, E. & Baquero, F. (1994). In vitro antibiotic selective concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrobial Agents and Chemotherapy 38, 122-5.
23. Dabernat, H., Geslin, P., Megraud, F., Begue, P., Boulesteix, J., Dubreuil, C. et al. (1998). Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. Journal of Antimicrobial Chemotherapy 41, 253-8.
24. Baquero, F. (1996). Antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 117-32.
25. Pankuch, G. A., Jueneman, S. A., Davies, T. A., Jacobs, M. R. & Applebaum, P. C. (1998). In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 42, 2914-8.
26. Thorburn, C. E., Knott, S. J. & Edwards, D. I. (1998). In vitro activities of oral β-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance. Antimicrobial Agents and Chemotherapy 42, 1973-9.
27. Baquero, F. (1999). Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? Journal of Chemotherapy 11, Suppl. 1, 35-43.
28. Baquero, F. (1996). Epidemiology and management of penicillin-resistant pneumococci. Current Opinion in Infectious Diseases 9, 372-9.
29. Qureshi, S. T., Skamene, E. & Mallo, D. (1999). Comparative genomics and host resistance against infectious diseases. Emerging Infectious Diseases 5, 36-47.
30. Cohen, R. & Varon, E. (2001). Variations de la flore oro- et rhinopharyngée en dehors des antibiotiques. La Lettre de l'Infectiologue 7, 4-8.
31. Orero, A., González, J. & Prieto, J. (1997). Antibiotics in Spanish households. Medical and socioeconomical implications. URANO Study Group. Medicina Clínica 109, 782-5.
32. Loda, F. A., Collier, A. M., Glezen, W. P., Strangert, K., Clyde, W. A. & Denny, F. W. (1975). Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. Journal of Pediatrics 87, 1087-93.
33. Sá-Leao, R., Tomasz, A., Santos-Sanches, I., Nunes, S., Alves, C. R., Brito-Avô, A. et al. (2000). Genetic diversity and clonal patterns among antibiotic-susceptible and -resistant Streptococcus pneumoniae colonizing children: day care centres as autonomous epidemiological units. Journal of Clinical Microbiology 38, 4137-44.
34. Sá-Leao, R., Tomasz, A., Santos-Sanches, I., Brito-Avô, A., Vilhelmsson, S. E., Kristinsson, K. G. et al. (2000). Carriage of internationally spread clones of Streptococcus pneumoniae with unusual drug resistance patterns in children attending day care centres in Lisbon, Portugal. Journal of Infectious Diseases 182, 1153-60.
35. Moreno, R. (2000). Ph.D. Thesis, School of Medicine, Universidad Complutense de Madrid, Spain.
36. Monnet, D. (2001). European Conference on Antibiotic Consumption, ESAC November 2001. http://oms2.b3e.jussieu.fr-/flunet/activity.html
37. Dagan, R., Givon-Lavi, N., Zamir, O., Sikuler-Cohen, M., Guy, L., Janco J. et al. (2002). Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centres. Journal of Infectious Diseases 185, 927-36.
38. Cosentino, M., Leoni, O., Banfi, F., Lecchini, S. & Frigo, G. (2000). An approach for the estimation of drug prescribing using the defined daily dose methodology and drug dispensation data. European Journal of Clinical Pharmacology 56, 513-7.